Details of Drug-Drug Interaction
| Drug General Information (ID: DDIWKU3FZ4) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Sparfloxacin | Drug Info | Ferrous sulfate anhydrous | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antibiotics | Iron Supplement | |||||||
| Structure | |||||||||
| Mechanism of Sparfloxacin-Ferrous sulfate anhydrous Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Complex formation Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Sparfloxacin | Ferrous sulfate anhydrous | |||||||
| Mechanism | Binds to polyvalent cations | Polyvalent cations | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Chelation | ||||||||
| Factor Description | Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | When coadministration cannot be avoided, quinolone antibiotics should be dosed either 2 to 4 hours before or 4 to 6 hours after polyvalent cation-containing products to minimize the potential for interaction. | ||||||||

